Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1489
Small font sizeDefault font sizeIncrease font size
Navigate here
Resource links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »  Article in PDF (432 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)  

  In this article
 »  Abstract
 » Introduction
 »  Materials and Me...
 » Results
 » Discussion
 »  References

 Article Access Statistics
    PDF Downloaded69    
    Comments [Add]    

Recommend this journal


  Table of Contents  
Year : 2020  |  Volume : 57  |  Issue : 2  |  Page : 187-189

Genetic polymorphism of hOGG1 ser326cys and its association with breast cancer in Jammu and Kashmir

1 School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India
2 Department of Oncology, Shri Mata Vaishno Devi Superspeciality Narayana Hospital, Katra, Jammu and Kashmir, India

Date of Submission16-Oct-2018
Date of Decision01-Nov-2018
Date of Acceptance06-Feb-2019
Date of Web Publication09-Mar-2020

Correspondence Address:
Rakesh Kumar
School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijc.IJC_676_18

Rights and Permissions

 » Abstract 

Background: 8-Oxo-7, 8-dihydro-2'-deoxyguanosine (8-oxodG) is a potent DNA damage marker that leads to cellular oxidative stress. It is a DNA-repair enzyme that participates in “8-oxodG” DNA adducts removal. Previous studies show weak associations of rs1052133 (hOGG1) in breast cancer patients of Northern India. We performed this study to explore the variant rs1052133 (hOGG1) with breast in the population of Jammu and Kashmir (J and K).
Method: A polymerase chain reaction–restriction fragment length polymorphism -based single-nucleotide polymorphism (SNP) genotypic study was carried out in peripheral blood samples of 165 breast cancer patients and 200 healthy controls, using specific primers. Sanger sequencing verified the results.
Results: hOGG1-Ser326Cys polymorphism occurred frequently in cases as compared with controls. Data were evaluated by SPSS V.13 software, following Hardy–Weinberg equilibrium (P = 0.002 at OR 2.57; 95% CI [1.68–3.93]), which showed that the SNP rs1052133 had a significant association with increased risk of breast cancer.
Conclusion: Overall, the results of this analysis show that the hOGG1-Ser326Cys polymorphism may be associated with an increased risk for breast cancer in the J and K population.

Keywords: 8-oxodG, Base excision repair, DNA repair, human 8-oxoguanine DNA glycosylase, oxidative stress, reactive oxygen species

How to cite this article:
Nagpal A, Verma S, Shah R, Bhat GR, Bhat A, Bakshi D, Sharma B, Kaul S, Kumar R. Genetic polymorphism of hOGG1 ser326cys and its association with breast cancer in Jammu and Kashmir. Indian J Cancer 2020;57:187-9

How to cite this URL:
Nagpal A, Verma S, Shah R, Bhat GR, Bhat A, Bakshi D, Sharma B, Kaul S, Kumar R. Genetic polymorphism of hOGG1 ser326cys and its association with breast cancer in Jammu and Kashmir. Indian J Cancer [serial online] 2020 [cited 2021 Jan 24];57:187-9. Available from:

 » Introduction Top

Breast cancer is one of the leading causes of death in women throughout the world.[1] Various genome-wide association studies' analyses found that rs1052133 of the hOGG1 gene is associated with human cancers.[2],[3] The hOGG1 gene plays an important role in the base excision repair (BER) pathway.[4] The main role of the hOGG1 gene in the BER pathway is to recognize the lesion 8-hydroxy-2'-deoxyguanine (8-OH-dG) and its excision.[5] It acts as a scaffold for other DNA repair genes like XRCC1, APE1, Pol β, and LIG3. Environmental exposure and dietary habits influence the function of these genes that increases the breast cancer risk. A similar case–control study in colorectal carcinoma found no association in the Kashmiri population.[6] Saudi and Polish studies have found hOGG1-Ser326Cys to be strongly associated with breast cancer in their respective populations. In India, a few studies have shown its association with breast cancer.[4],[7],[8],[9] We designed this study to explore the variant rs1052133 (hOGG1) with breast cancer in the population of the Jammu and Kashmir (J and K), India.

 » Materials and Methods Top


The study recruited 165 breast carcinoma patients and 200 healthy ethnicity-matched and age-matched women. Clinical details are given in [Table 1]. 2-3 ml of blood was collected from breast patients and normal healthy females (age and sex matched) of Jammu and Kashmir region and controls were collected by random sampling and stored in Ethylenediamine tetraacetic acid (EDTA) vials at –20°C until the time of DNA isolation. The genomic DNA was extracted using the manufacturer protocol of DNA Isolation Kit (Qiagen Kit). DNA concentration and quality were checked using a Nano-Drop Bio spectrophotometer (Eppendorf India Limited, Ambattur, Chennai) and agarose gel electrophoresis (Bio-Rad and Gel Doc EZ image-Bio-Rad House, Gurugram, Haryana), respectively.{Table 1}


The hOGG1 Ser326Cys polymorphism was assessed by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) using primers from a previous study.[7] The reaction mixture of PCR having 25 μL (total PCR reaction mix is 25μL) volume contains 0.5 μL Forward and Reverse Primer, 2.0 μL (50 ng/μL) of genomic DNA, 9.5 μL dH2O, and 12.5 μL master mix (MgCl2, dNTPs, Taq Polymerase) (Sigma Aldrich Srivastava Market, Hauz Khas, Delhi). For the PCR amplification process in a thermal cycler (Eppendorf India, Ambattur, Chennai), each step consisted of a 5-min denaturation at 94°C followed by 35 cycles of 94°C for 30 s, annealing at 58°C for 30 s and extension at 72°C for 1 min, and 72°C for 7 min. We used RFLP method to identify the Ser326Cys variant because the C-to-G transversion creates a new Fnu4HI (NEBL) restriction site (Thermo Fisher Scientific Pvt. Ltd, Hiranandani Business Park, Mumbai, Maharashtra). Fragments were separated on a 2% agarose gel and results were validated by Sanger Sequencing (Ms. Agri Genome Pvt. Ltd, Cochin and Kerala, India). The chromatograms were analyzed by ChromasPro V.2.6.4.

 » Results Top

The 200 bp PCR product is digested by Sat1 (Fnu4HI) creating two 100 bp fragments for the 326Cys variant and is undigested for the 326Ser allele at exon 7. The chromatograms showed Ser/Cys heterozygote (C/G), Ser/Ser homozygote (C/C), and Cys/Cys homozygote (G/G) [Figure 1]. SNP polymorphism at Ser326Cys (rs1052133) at exon7 of chr3p25 positioned at codon326 in the hOGG1 gene had a significant association with breast cancer. The analysis was done in 200 healthy controls and 165 breast cancer patients using SPSS V.13 software, following Hardy–Weinberg equilibrium (HWE). Genotypic distribution, risk allele frequency, risk estimation, and association details are summarized in [Table 1]. The observed odds ratio of risk allele 'G' is 1.24 (0.71–2.16) and HWE = 0.893 for cases and 0.446 in controls, that predisposes them to a greater risk of having breast cancer, because of oxidative DNA damage. The covariates taken for the analysis included age and BMI.{Figure 1}

 » Discussion Top

We found an association of rs1052133 of the hOGG1 gene with breast cancer in the J and K population and it has highlighted the role of the gene in a predisposition towards breast cancer in the population. The hOGG1 Ser326Cys was selected because of its critical role in genome integrity. It was reported that hOGG1 Ser326 Cys has deleterious effect on different cancers world wide.[10] In Asian, Caucasian, and Chinese populations, this SNP showed a strong association with cancers like ovarian, lung, prostate, gastric etc.[11],[12] In Polish women, it showed a strong association with breast cancer and is even used as a biomarker in breast cancer patients.[13] Pakistani women showed a strong association of this SNP with breast cancer.[4] The variant rs1052133 under study also showed a strong association with breast cancer in the Indian population,[4] whereas the study in the ethnic Kashmiri population of India in colorectal cancer had no association of this SNP.[6] No such study has been carried in breast cancer patients of the J and K region.

Alanazi et al. found protein structural destabilization of OGG1 mutant 326cys on simulation. Mutant residues are more hydrophobic and have deleterious effects on the function of the hOGG1 protein by affecting the enzymatic activities of DNA glycosylases, lyase, and hydrolase.[9] Hill and Evans et al. conducted in vivo functional studies using deletion mutants and confirmed the DNA-binding and enzymatic activity of hOGG1.[14] Simonelli et al. found the lower enzymatic activity and DNA damage and repair potential of purified Cys326Cys mutant protein in an in vitro base excision assay.[10] In this case–control study, Ser326Cys SNP was found to be significantly associated with the increased risk of breast cancer. The current findings suggested that allele G of SNP rs1052133 act as a risk factor in females of the J and K region. This is the first report from the J and K population, which shows strong association with breast cancer. In the future, it may act as a biomarker for breast cancer screening programmes.


The authors thank the DST and Govt. of Jammu and Kashmir for funding this project. Funding for this study was sanctioned by DST-SERB, GOI with the sanctioned number: YSS/2014/000659.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

Ethical approval

The present study was approved by the Institutional Ethics Review Board [IERB] of Shri Mata Vaishno Devi University with approved serial no. SMVDU/IERB/14/28.

 » References Top

Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017;67:7-30.  Back to cited text no. 1
Wang T, Wang H, Yang S, Guo H, Zhang B, Guo H, et al. Association of APEX1 and OGG1 gene polymorphisms with breast cancer risk among Han women in the Gansu Province of China. BMC Med Genet 2018;19:67.  Back to cited text no. 2
Wang W, Dang S, Li Y, Sun M, Jia X, Wang R, et al. hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among East Asians: A meta-analysis. PLoS One 2013;8:e60178.  Back to cited text no. 3
Ali K, Mahjabeen I, Sabir M, Mehmood H, Kayani MA. OGG1 mutations and risk of female breast cancer: Meta-analysis and experimental data. Dis Markers 2015. doi: 10.1155/2015/690878.  Back to cited text no. 4
Martins GV, Marques AC, Fortunato E, Sales MGF. 8-hydroxy-2'-deoxyguanosine [8-OHdG] biomarker detection down to picoMolar level on a plastic antibody film. Biosens Bioelectron 2016;86:225-34.  Back to cited text no. 5
Sameer AS, Nissar S, Abdullah S, Chowdri NA, Siddiqi MA. DNA repair gene 8-oxoguanine DNA glycosylase Ser326Cys polymorphism and colorectal cancer risk in a Kashmiri population. DNA Cell Biol 2012;31:541-6.  Back to cited text no. 6
Smolarz B, Makowska M, Samulak D, Michalska MM, Mojs E, Wilczak M, et al. Single nucleotide polymorphisms [SNPs] of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women. Tumour Biol 2014;35:3495-502.  Back to cited text no. 7
Pramanik S, Surendran ST, Arumugam S, Devi S, Krishnamurthi K, Chakrabarti T. Polymorphisms in DNA repair and multidrug resistance genes among Sindhis of Central India. Environ Toxicol Pharmacol 2015;40:480-5.  Back to cited text no. 8
Alanazi M, Pathan AAK, Shaik JP, Alhadheq A, Khan Z, Khan W, et al. The hOGG1 Ser326Cys gene polymorphism and breast cancer risk in saudi population. Pathol Oncol Res 2017;23:525-35.  Back to cited text no. 9
Simonelli V, Camerini S, Mazzei F, Van Loon B, Allione A, D'Errico M, et al. Genotype-phenotype analysis of S326C OGG1 polymorphism: A risk factor for oxidative pathologies. Free Radic Biol Med 2013;401-9.  Back to cited text no. 10
Peng Y, Li Z, Zhang S, Xiong Y, Cun Y, Qian C, et al. Association of DNA base excision repair genes [OGG1, APE1 and XRCC1] polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients. Int J Cancer 2014;135:2687-96.  Back to cited text no. 11
Chen L, Liu M-M, Liu H, Lu D, Zhao X-D, Yang X-J. ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma. Onco Targets Ther 2016;9:7019-28.  Back to cited text no. 12
Michalska MM, Samulak D, Romanowicz H, Bienkiewicz J, Sobkowski M, Ciesielski K, et al. Single nucleotide polymorphisms [SNPs] of hOGG1 and XRCC1 DNA repair genes and the risk of ovarian cancer in Polish women. Tumour Biol 2015;36:9457-63.  Back to cited text no. 13
Hill JW, Evans MK. Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res 2006;34:1620-32.  Back to cited text no. 14


Print this article  Email this article


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow